Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 1,263 1.45%
11 Aug - close price
maxhealthcare.in BSE: 543220 NSE: MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership
The company is India’s 2nd largest hospital chain in terms of hospital revenue, EBITDA, and market capitalization. [1]

Website BSE NSE
  • Market Cap ₹ 1,22,890 Cr.
  • Current Price ₹ 1,263
  • High / Low ₹ 1,314 / 837
  • Stock P/E 163
  • Book Value ₹ 85.3
  • Dividend Yield 0.12 %
  • ROCE 12.5 %
  • ROE 9.45 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 203% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 18.7%

Cons

  • Stock is trading at 14.8 times its book value
  • Company has a low return on equity of 9.70% over last 3 years.
  • Debtor days have increased from 33.1 to 40.5 days.
  • Promoter holding has decreased over last 3 years: -26.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare BSE 100 BSE 200 Nifty 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
393 440 474 482 507 544 597 591 610 621 686 697 659
298 317 322 328 354 384 394 391 407 423 461 461 484
Operating Profit 96 123 152 154 154 160 203 200 203 198 225 236 175
OPM % 24% 28% 32% 32% 30% 29% 34% 34% 33% 32% 33% 34% 27%
27 29 32 44 41 43 48 43 134 43 134 18 98
Interest 13 13 13 13 14 14 13 10 15 8 8 23 9
Depreciation 28 28 28 28 30 28 28 30 32 30 32 33 36
Profit before tax 82 111 144 157 151 161 210 203 291 203 318 198 227
Tax % 19% 22% -149% 22% 16% 22% 23% 22% 17% 24% 27% 30% 22%
67 87 359 122 126 126 161 158 242 154 231 138 177
EPS in Rs 0.69 0.90 3.70 1.26 1.30 1.30 1.66 1.63 2.49 1.59 2.38 1.42 1.82
Raw PDF
Upcoming result date: 13 August 2025

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
591 790 912 984 1,059 1,008 59 1,031 1,775 1,905 2,341 2,664
615 768 890 941 1,048 976 65 870 1,332 1,321 1,574 1,830
Operating Profit -24 22 22 43 11 31 -6 161 443 584 767 833
OPM % -4% 3% 2% 4% 1% 3% -10% 16% 25% 31% 33% 31%
39 33 35 30 51 47 66 -104 128 144 266 293
Interest 42 43 30 35 41 44 60 112 59 52 52 48
Depreciation 31 49 50 51 49 53 3 91 112 113 117 131
Profit before tax -58 -38 -24 -13 -28 -18 -3 -146 400 563 865 947
Tax % 0% 0% -0% 0% 0% 26% -5% 12% 17% -23% 21% 26%
-58 -38 -24 -13 -28 -23 -3 -164 332 694 687 701
EPS in Rs -1.46 -0.78 -0.44 -0.24 -0.51 -0.43 -0.06 -1.70 3.42 7.15 7.07 7.21
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 14% 21% 21%
Compounded Sales Growth
10 Years: 13%
5 Years: 114%
3 Years: 14%
TTM: 14%
Compounded Profit Growth
10 Years: 36%
5 Years: 203%
3 Years: 32%
TTM: 10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 52%
1 Year: 43%
Return on Equity
10 Years: 6%
5 Years: 8%
3 Years: 10%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 395 489 533 537 537 537 537 966 970 971 972 972
Reserves 167 523 762 770 773 749 2,338 4,973 5,342 6,071 6,709 7,317
505 296 273 314 386 390 658 480 556 534 443 612
223 141 171 210 278 274 20 724 945 845 945 1,065
Total Liabilities 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069 9,967
468 430 424 429 502 479 90 2,989 4,493 4,485 4,717 4,871
CWIP 10 15 6 30 7 10 0 8 60 103 235 277
Investments 238 451 840 866 799 770 2,471 2,379 1,447 1,475 1,915 2,614
574 554 469 508 665 693 992 1,766 1,811 2,358 2,202 2,206
Total Assets 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069 9,967

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
39 64 33 52 -19 128 224 447 696 613 598
-200 -330 -66 -89 55 -193 -105 -670 302 -806 -873
176 251 34 36 -36 329 412 -161 -54 -246 -29
Net Cash Flow 15 -16 0 -0 -0 265 532 -384 944 -439 -304

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 97 67 48 55 68 103 517 109 56 27 32 40
Inventory Days 18 20 18 19 22 25 33 20 31 24 20
Days Payable 158 171 183 206 250 335 297 159 226 209 191
Cash Conversion Cycle -42 -85 -117 -132 -161 -206 517 -155 -83 -169 -153 -130
Working Capital Days -54 -15 -33 -20 -27 14 -493 27 5 -45 -32 -24
ROCE % 0% 1% 1% 2% 2% 4% 7% 9% 12% 13%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
23.80% 23.78% 23.77% 23.76% 23.76% 23.75% 23.75% 23.74% 23.74% 23.74% 23.74% 23.74%
49.27% 50.15% 51.96% 59.89% 60.39% 60.69% 57.33% 56.99% 57.29% 56.93% 54.74% 54.76%
21.16% 20.47% 19.36% 11.90% 11.40% 11.55% 14.96% 15.36% 15.14% 15.55% 17.59% 17.41%
5.76% 5.61% 4.92% 4.45% 4.45% 3.99% 3.97% 3.91% 3.84% 3.77% 3.94% 4.09%
No. of Shareholders 1,01,6591,11,7011,04,6561,11,3741,18,6351,11,3381,27,0091,36,2541,37,8561,40,0281,51,6331,62,119

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls